Zoulim F, Lenz O, Vandenbossche JJ, Talloen W, et al. JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection. Gastroenterology 2020;159:521-533.
PMID: 32343960